KIT and gastrointestinal stromal tumor: Mutations in the genes encoding the receptor tyrosine kinase protein (KIT) and platelet-derived growth factor receptor-α (PDGFRA) account for approximately 60–70% and 10–15% of GIST, respectively [1].